In response to the FDA’s alert in July about the possibility of serotonin syndrome when people on antidepressants use triptans, HEADQuarters Migraine Management has released special bulletin on serotonin syndrome and medications. It’s a clear explanation of what migraineurs need to know about the illness.
I linked to the February/March issue of the HEADQuarters newsletter in my first post about serotonin syndrome. This contains some of the same information, but the special bulletin relates directly to the FDA’s announcement. It’s worth checking out.